ICD-Implantation - Bei welchen Patienten ist ihr Wert in der Primärprophylaxe gesichert?

Schlüsselwörter

ICD-Implantation - Primärprophylaxe - Indikation

Key words

defibrillator implantation - primary prevention - indications

Literatur

• 1 Bänsch D, Antz M, Boczor S. et al . Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy. The Cardiomyopathy Trial (CAT).  Circulation. 2002;  105 1453-1458
• 2 Bardy G H, Lee K L, Mark D B. et al. for the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators . Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.  N Engl J Med. 2005;  352 225-237
• 3 Bigger J T. for the Coronary Artery Bypass Graft (CABG) Patch Trial Investigators . Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery.  N Engl J Med. 1997;  337 1569-1575
• 4 Bloomfield D M, Bigger J T, Steinman R C. et al . Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction.  J Am Coll Cardiol. 2006;  47 456-463
• 5 Bloomfield D M, Steinman R C, Namerow P B. et al . Microvolt T-Wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: A solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II.  Circulation. 2004;  110 1885-1889
• 6 Bristow M R, Saxon L A, Boehmer J. et al. for the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) Investigators . Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.  N Engl J Med. 2004;  350 2140-2150
• 7 Buxton A E, Lee K L, Fisher J D. et al., for the Multicenter Unsustained Tachycardia Trial Investigators . A randomized study of the prevention of sudden death in patients with coronary artery disease.  N Engl J Med. 1999;  341 1882-1890
• 8 Cleland J GF, Daubert J C, Erdmann E. et al . The effect of cardiac resynchronization on morbidity and mortality in heart failure.  N Engl J Med. 2005;  352 1539-1549
• 9 Cohn J N, Bristow M R, Chien K R. et al . Report of the national Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research.  Circulation. 1997;  95 766-770
• 10 Connolly S J, Gent M, Roberts R S. et al. for the CIDS investigators . Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter against amiodarone.  Circulation. 2000;  101 1297-1302
• 11 Gregoratos G. ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee on Pacemaker Implantation). www.acc.org/clinical/guidelines/pacemaker
• 12 Hohnloser S H, Kuck K H, Dorian P. et al . Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.  N Engl J Med. 2004;  351 2481-2488
• 13 Kadish A. Prophylactic defibrillator implantation - toward an evidence-based approach.  N Engl J Med. 2005;  352 285-287
• 14 Kadish A, Dyer A, Daubert J P. et al. for the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators . Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.  N Engl J Med. 2004;  350 2151-2158
• 15 Kuck K H, Cappato R, Siebels J. et al . Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH).  Circulation. 2000;  101 7481-7454
• 16 Moss A J. Should everyone with an ejection fraction less than or equal to 30 % receive an implantable cardioverter-defibrillator?.  Circulation. 2005;  111 2735-2749
• 17 Moss A J, Brown M W, Cannom D S. et al . Multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT): design and clinical protocol.  Ann Noninvasive Electrocardiol. 2005;  10 34-43
• 18 Moss A J, Daubert J, Zareba W. MADIT-II: Clinical Implications.  Card Electrophysiol Rev. 2002;  6 463-465
• 19 Moss A J, Hall W J, Cannom D S. et al., for the Multicenter Automatic Defibrillator Implantation Trial Investigators . Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia.  N Engl J Med. 1996;  335 1933-1940
• 20 Moss A J, Zareba W, Hall W J. et al., for the Multicenter Automatic Defibrillator Implantation Trial II Investigators . Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.  N Engl J Med. 2002;  346 877-883
• 21 Myerburg R J. Sudden cardiac death:exploring the limits of our knowledge.  J Cardiovasc Electrophysiol. 2001;  12 369-381
• 22 Myerburg R J, Castellanos A. Spend in the beginning or pay at the end.  J Am Coll Cardiol. 2006;  47 108-111
• 23 Olshansky B, Poole J E, Johnson G W. et al. for the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators .Syncope predicts the outcome of cardiomyopathy patients - analysis of the SCD-HeFT Trial. AHA Scientific Sessions 2005
• 24 Sharma A, Poole J E, Anderson J. et al. for the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators .Mortality in non-ischemic dilated cardiomyopathy with LVEF >35 % during follow up in the Sudden Cardiac Death in Heart Failure trial. AHA Scientific Sessions 2005
• 25 Strickberger S A, Hummel J D, Bartlett T G. et al . Amiodarone Versus Implantable Cardioverter-Defibrillator: Randomized Trial in Patients With Nonischemic Dilated Cardiomyopathy and Asymptomatic Nonsustained Ventricular Tachycardia - AMIOVIRT.  J Am Coll Cardiol. 2003;  41 1707-1712
• 26 The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators . A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients rescuscitated from near-fatal ventricular arrhythmias.  N Engl J Med. 1997;  337 1576-1583
• 27 Vyas A, Moss A J, Zareba W. et al . Risk stratification of MADIT-II patients for predicting mortality and ICD benefit.  Circulation. 2004;  110 III-503